(Press-News.org) Researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients' health, nor does it reduce their risk of death from heart failure. Results of the international study were presented at the American College of Cardiology's annual meeting in San Francisco on March 10 and published simultaneously online by The New England Journal of Medicine.
Initiated in 2006, the RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) trial involved 2,278 anemic heart failure patients at 453 sites in 33 countries.
Patients were randomly given either darbepoetin alfa or placebo. In the darbepoetin alfa group, 50.7 percent of the patients experienced death from any cause or hospitalization for worsening heart failure. In the placebo group, 49.5 percent of the patients experienced similar clinical outcomes.
The trial was funded by Amgen, the maker of darbepoetin alfa (trade name: Aranesp).
"This landmark study provides answers to caregivers who treat patients with heart failure complicated by anemia," says James Young, M.D., cardiologist and Chair of the Cleveland Clinic Endocrinology & Metabolism Institute, and co-investigator of the RED-HF trial.
"Our findings do not support the use of darbepoetin alfa to treat anemic heart failure patients."
Anemia, the lack of red blood cells, is a common and serious problem in people who suffer from heart failure. It can lead to worse quality of life, higher rates of hospitalization and death. Treatment options have focused on correcting anemia with the use of intravenous iron or drugs that stimulate red blood cells.
"The benefits of erythropoietin-stimulating agents (ESAs) such as darbepoetin alfa to treat patients with heart failure and anemia have been questioned due to contradictory research findings," says Karl Swedberg, M.D., Ph.D., a senior professor at the Sweden-based Department of Medicine, Sahlgrenska Academy, University of Gothenburg, and co-investigator of the RED-HF trial.
"Our study results show that the use of darbepoetin alfa to stimulate the production of red blood cells is an ineffective treatment for patients with heart failure and anemia."
According to the study, researchers found that darbepoetin alfa treatment led to an early and sustained increase in hemoglobin compared with placebo. However, darbepoetin alfa treatment did not reduce the risk of death from any cause or hospitalization from heart failure.
Findings suggest that hemoglobin is a marker of poor prognosis in heart failure, rather than a therapeutic target. There were no new safety findings identified in the study. However, researchers observed an increased risk of thrombosis in the darbepoetin alfa group.
Researchers note that further research is needed to identify treatment options for this patient population.
### Link to article: http://www.nejm.org/doi/full/10.1056/NEJMoa1214865
Contact:
Karl Swedberg, senior professor at the Sahlgrenska Academy, University of Gothenburg
+46 707144747
karl.swedberg@gu.se
Des Moines, IA – A new study by researchers at the University of Arizona and Northwest Missouri State University shows that standing and lying behavior can predict heat stress in cows.
In a presentation at the 2013 ADSA Midwest Branch / ASAS Midwestern Section Meeting, Dr. Jamison Allen explained that predicting heat stress is vital for keeping cows healthy and productive. Cows will pant, eat less and produce less milk when their core body temperature increases.
Allen said cows prefer standing to lying on hot days. Cows stand to allow more of their surface area to disperse ...
Philadelphia, Pa. (March 12, 2013) – Ten years after stroke caused by a ruptured aneurysm of the brain, surviving patients have persistent difficulties in several areas affecting quality of life, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The long-term impact of ruptured aneurysms causing subarachnoid hemorrhage (SAH) highlights the need for "survivorship care plans" comparable to those made for long-term cancer ...
Pity the poor maxillary sinuses. Those bulbous pouches on either side of the human nose are known more for trapping mucus and causing sinus infections than anything else. They were thought to be an evolutionary relic of our distant past, with little known present value.
Yet researchers led by the University of Iowa believe the unheralded maxillary sinuses play a fortuitous, integral role in the shape and function of the human nose, even today. After studying faces of African and European origin, the team has concluded that the maxillary sinuses act as a cushion of sorts, ...
Philadelphia, PA, March 12, 2013 – Cognitive impairments are disabling for individuals with schizophrenia, and no satisfactory treatments currently exist. These impairments affect a wide range of cognition, including memory, attention, verbal and motor skills, and IQ. They appear in the earliest stages of the disease and disrupt or even prevent normal day-to-day functioning.
Scientists are exploring a variety of strategies to reduce these impairments including "exercising the brain" with specially designed computer games and medications that might improve the function ...
Antibiotic-resistant Escherichia coli (E. coli) continues to proliferate, driven largely by expansion of a strain of E. coli know as sequence type ST131. A new study points to hospitals and long-term care facilities (LTCF) as settings in which this antibiotic-resistant strain is increasingly found. The study is published in the April issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
E. coli is the most common gram-negative pathogen, causing both gastrointestinal disease and extraintestinal infections ...
Infants as young as nine months old prefer individuals who punish those who are not like them, and this seemingly innate mean streak grows stronger in the next five months of life, a study by researchers at Yale University has found.
Babies, like adults, prefer individuals who like the same things they do. A new study reports that they want individuals who share their tastes to be treated well by others, but want those whose tastes differ from their own to be treated badly. The study of 200 nine- and 14-month-old infants was published online in Psychological Science, ...
As network carriers debate the next Ethernet standard—and whether transmission speeds of 400 gigabit per second or 1 terabit per second should be the norm—engineers are working on new measures to squeeze next-generation performance out of current-generation systems.
To that end, a team from AT&T has devised a new patent pending technique enabling tuning of the modulation spectral efficiency, which allows, for the first time, 400 Gb/s signals to be sent over today's 100 gigahertz-grid optical networks over ultra-long distances. Spectral efficiency is the information rate ...
Americans work longer hours, take fewer vacation days, and retire later than employees in other industrialized countries around the globe. With such demanding careers, it's no surprise that many experience job burnout — physical, cognitive, and emotional exhaustion that results from stress at work. Researchers have found that burnout is also associated with obesity, insomnia, and anxiety.
Now Dr. Sharon Toker of Tel Aviv University's Faculty of Management and her fellow researchers — Profs. Samuel Melamed, Shlomo Berliner, David Zeltser and Itzhak Shpira of TAU's Sackler ...
Ultrafast supercomputers that operate at speeds 100 times faster than current systems are now one step closer to reality. A team of IBM researchers working on a U.S. Defense Advanced Research Projects Agency (DARPA)-funded program have found a way to transmit massive amounts of data with unprecedentedly low power consumption.
The team will describe their prototype optical link, which shatters the previous power efficiency record by half at the Optical Fiber Communication Conference and Exposition/National Fiber Optic Engineers Conference (OFC/NFOEC) in Anaheim, Calif. ...
New multicore optical fibers have many times the signal-carrying capacity of traditional single-core fibers, but their use in telecommunications has been severely restricted because of the challenge in splicing them together-- picture trying to match up and connect two separate boxes of spaghetti so that all of the noodles in each box are perfectly aligned. Now, a new splicing technique offers an automated way to do just that, with minimal losses in signal quality across the spliced sections. The method will be described at the Optical Fiber Communication Conference and ...
